Corbus Pharmaceuticals Holdings, Inc. (CRBP) KPIs and segments
Close on Nov 17, 2026Market cap $58.22MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Corbus Pharmaceuticals's business
Corbus Pharmaceuticals's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
Australia($M) | -0.01 | -0.03 | -0.02 | 0.05 | 0.06 | |
United Kingdom($M) | -26.2 | -8.72 | -8.46 | -7.55 | 3.02 | |
United States($M) | -52.3 | -31.5 | -36.1 | -34.8 | -48.7 | |
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-03-09.
See a number that looks wrong?